Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OUS Approvals Analysis: Expanded CoreValve Indication And Zika IVDs Among August’s CE Marks

Sep 14 2016

• By Reed Miller

Related Content

Data And More Data Expected To Drive BTG Towards Triple-Growth Target

Dec 31 2015

APPROVALS ANALYSIS: Big Jump In CE Marks, But Slow August For PMAs

Sep 17 2015

Neuro Medtech Investors Have Time (And Money) For The Pain

Nov 11 2015

Zika Assay Reviews Are Testing The Limits Of FDA Capacity, Shuren Says

Sep 12 2016

US FDA Approves First Intermediate-Risk Indication For TAVR

Aug 18 2016

Expanded Indication For Edwards’ Sapien 3 Squarely In Sight

Apr 06 2016

BTG snaps up Biocompatibles

Nov 19 2010

Related Companies

Edwards Lifesciences Corp.

BTG plc

Boston Scientific Corporation

Nordion

ViewRay, Inc.

Additional Topics

Asia Pacific Europe Commercial Approvals Research & Development Companies Innovation Medical Device

More from Business

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window